Sales & Marketing News | pharmaphorum

News

GSK turning a corner as sales, profits forecasts rise

GSK looks like it is starting to show the benefit of a revamp of its business under chief executive Emma Walmsley, with recent product launches driving a 10% rise in sales

News

FTC steps up campaign on junk patents with warning letters

The US Federal Trade Commission (FTC) has expanded its campaign against so-called ‘junk’ patents intended to extend market exclusivity and block generic rivals.

News

Walmart retreats from healthcare, closing clinics across US

For the last few years, Walmart has been promising to disrupt the US healthcare sector with a national network of clinics providing low-cost care and telehealth services.

News

California to sell state-branded Narcan generic to cut costs

California has said it will start selling its own generic version of overdose reversal agent naloxone in another example of the use of government-level purchasing power to

News

BMS, J&J challenges to Medicare negotiations are thrown out

In another setback for the pharma industry, a US federal judge has rejected a bid to overturn the Medicare pricing negotiation brought by Bristol-Myers Squibb and Johnson

News

X4 Pharma gets first FDA okay for WHIM syndrome drug

Patients in the US with the ultra-rare disease WHIM syndrome now have their first approved treatment, after X4 Pharma’s Xolremdi was given a green light by the FDA.

GSK turning a corner as sales, profits forecasts rise

FTC steps up campaign on junk patents with warning letters

Walmart retreats from healthcare, closing clinics across US

California to sell state-branded Narcan generic to cut costs

BMS, J&J challenges to Medicare negotiations are thrown out

X4 Pharma gets first FDA okay for WHIM syndrome drug

Astellas pays $285m for Audax cancer drug, and other deals

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks